Trulieve CannabisTRLV -0.35%63 FCF Yield % is 13.72 as of Jun. 25, 2026. GuruFocus rates TRLV with a GF Score™ of 63/100 and a GF Value™ of $6.03 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Trulieve Cannabis ranks better than 91.74% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Trulieve Cannabis FCF Yield % Related Terms
Trulieve Cannabis FCF Yield % Historical Data
* Premium members only.
The historical data trend for Trulieve Cannabis's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trulieve Cannabis FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Trulieve Cannabis's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trulieve Cannabis (TRLV) has a FCF Yield % of 13.72 as of Jun. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Trulieve Cannabis and its competitors. According to the industry distribution chart, Trulieve Cannabis ranks #83 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 8.3%.
Is Trulieve Cannabis' FCF Yield % too high?
Trulieve Cannabis' current FCF Yield % is 13.72. The Drug Manufacturers industry median FCF Yield % is 0.69. Trulieve Cannabis' value of 13.72 is 1888.4% above this industry median. Based on the distribution chart, Trulieve Cannabis ranks #83 out of 1005 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Trulieve Cannabis has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Trulieve Cannabis' FCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Trulieve Cannabis ranks #83 out of 1005 companies for FCF Yield %. This places Trulieve Cannabis in the top 8% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 0.69. Trulieve Cannabis' value of 13.72 is 1888.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.69, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trulieve Cannabis's current FCF Yield % of 13.72 is 1888.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Trulieve Cannabis and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trulieve Cannabis's current FCF Yield % is 13.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trulieve Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Trulieve Cannabis (TRLV) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.03, compared to a current price of $8.50 — trading 41% above its estimated fair value. The current FCF Yield % is 13.72 and 1888.4% above the Drug Manufacturers industry median of 0.69. Trulieve Cannabis' overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Trulieve Cannabis (TRLV), the current FCF Yield % is 13.72 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trulieve Cannabis (TRLV) Overvalued in 2026?
Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued.
The current stock price of $8.50 is trading 41% above its estimated GF Value™ of $6.03.
GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.
Key valuation signals for TRLV:
FCF Yield %: 13.72
GF Value™: $6.03 vs. price of $8.50 (41% above fair value)
Industry Position: 1888.4% above the Drug Manufacturers median (#83 of 1005)
No single metric tells the full story. See the TRLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
63GF Score
Get the complete analysis for TRLV
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TRLV has been successfully added to your 
